TY - JOUR
T1 - Modulation of anti-IgM-induced B cell apoptosis by Bcl-x(L) and CD40 in WEHI-231 cells
T2 - Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction
AU - Merino, R.
AU - Grillot, D. A.M.
AU - Simonian, P. L.
AU - Muthukkumar, S.
AU - Fanslow, W. C.
AU - Bondada, S.
AU - Nunez, G.
PY - 1995
Y1 - 1995
N2 - The demise of B cell progenitors expressing functional IgM receptors for self appears to be the main mechanism by which B cell tolerance is accomplished. The genetic mechanisms that regulate the death process during this critical step of B cell development are still poorly understood. We have studied the regulation of apoptosis in WEHI-231 lymphoma cells after treatment with a panel of anti-IgM mAbs as an in vitro model of clonal B cell deletion. We showed that a product of bcl-x, Bcl-x(L), can inhibit anti-IgM- induced apoptosis but not cell cycle arrest in a dose-dependent manner. Bcl- x(L0 was efficient in protecting B cells from low but not high avidity anti- IgM mAbs. In contrast to that observed with Bcl-x(L), CD40 stimulation was efficient in inhibiting both cell cycle arrest and apoptosis after IgM cross- linking regardless of the binding avidity of the anti-IgM Ab. Moreover, activation through IgM receptors but not CD40 induced up-regulation followed by rapid down-modulation of Bd-x(L). Thus, the capacity of Bcl-x(L) to modulate anti-IgM-induced apoptosis in WEHI-231 cells is highly dependent on the avidity of the Ab-IgM receptor interaction.
AB - The demise of B cell progenitors expressing functional IgM receptors for self appears to be the main mechanism by which B cell tolerance is accomplished. The genetic mechanisms that regulate the death process during this critical step of B cell development are still poorly understood. We have studied the regulation of apoptosis in WEHI-231 lymphoma cells after treatment with a panel of anti-IgM mAbs as an in vitro model of clonal B cell deletion. We showed that a product of bcl-x, Bcl-x(L), can inhibit anti-IgM- induced apoptosis but not cell cycle arrest in a dose-dependent manner. Bcl- x(L0 was efficient in protecting B cells from low but not high avidity anti- IgM mAbs. In contrast to that observed with Bcl-x(L), CD40 stimulation was efficient in inhibiting both cell cycle arrest and apoptosis after IgM cross- linking regardless of the binding avidity of the anti-IgM Ab. Moreover, activation through IgM receptors but not CD40 induced up-regulation followed by rapid down-modulation of Bd-x(L). Thus, the capacity of Bcl-x(L) to modulate anti-IgM-induced apoptosis in WEHI-231 cells is highly dependent on the avidity of the Ab-IgM receptor interaction.
UR - http://www.scopus.com/inward/record.url?scp=0029084999&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029084999&partnerID=8YFLogxK
M3 - Article
C2 - 7561089
AN - SCOPUS:0029084999
SN - 0022-1767
VL - 155
SP - 3830
EP - 3838
JO - Journal of Immunology
JF - Journal of Immunology
IS - 8
ER -